Cellular Therapy
Carter Bloodcare is a leader in advancing the cellular therapy (CT) field. Carter Bloodcare’s cellular therapy program supports both clinical and research use of cellular products. Our services include apheresis Cell Therapy collections, providing other CT source material, and processing/storage of multiple CT products. Our team has extensive experience in the cGMP manufacturing process. We have been performing CT collections and processing for over 20 years and have maintained continuous accreditation with FACT and AABB.
Research Collection and Laboratory Support
Cellular Therapy Starting Material
Carter BloodCare offers an array of CT source material that could be used in either clinical or research settings and includes:
Stem cells (mobilized leukopaks*)
Mononuclear cells (non-mobilized leukopaks*)
LRS chambers
Buffy coats
*All research leukopaks are collected using an IRB-approved consent and can be shipped fresh or frozen.
Cellular Therapy (CT) Laboratory Services
Carter BloodCare has state of the art facilities and team expertise to perform a wide variety of CT processing procedures specialized to meet each client’s needs. The CT laboratory is participating in several ongoing clinical trials, including CAR T-cell therapies, and serves as an essential partner of both pharma and academia in a number of studies that have taken new products through development, clinical trials and licensing. We can receive, store, deliver and thaw study protocol investigational products.
Our range of processes include:
Cryopreservation using controlled rate freezing method, which allows for long-term storage of cells
Long-term liquid nitrogen storage (colder than -150°C)
Thaw, reconstitution (if needed), and infusion
Quality control testing
US and International shipping available for frozen and fresh products
COA available upon request
Personalization of procedures to meet each client’s needs
Using the Quantum®, CliniMACS Prodigy® and CliniMACS® Plus, we provide researchers with simple and closed-system cell processing.
Cell selection and cell depletion
Mesenchymal cell expansion
CELLULAR THERAPY FACILITIES
Cleanroom Rental
The cleanrooms, located within Carter BloodCare’s headquarters in Bedford, Texas, are expected to be available for rent by Fall 2024 for researchers, science and technology firms, medical device companies and others who need to conduct temporary or permanent ISO compliant manufacturing. Click the button below to request more information or to reserve the dates and specific cleanrooms your company needs.
Clinical Program Collaboration
CT Collections for clinical programs
The Clinical Apheresis team at Carter BloodCare provides comprehensive support for cellular therapy clinical programs. Our team of apheresis specialists perform the collections for both pediatric and adult donors. We perform the collection of the following products in both hospital and outpatient settings for programs throughout Texas:
Autologous and allogeneic hematopoietic peripheral blood stem cells (HPCs)
Autologous and allogeneic mononuclear cells, including donor lymphocytes
We currently perform collections for several clinical trials and collaborate with clinical programs and trial sponsors to customize workflows and procedures based on protocols.
We also work closely with our clients throughout the pre-screening process by performing peripheral vein evaluation of the donor to determine venous access and by assisting to determine donor eligibility.
CT Laboratory Services for Clinical Programs
The cellular therapy (CT) laboratory provides services to multiple bone marrow transplant programs both within and outside of the Dallas - Fort Worth Metroplex. Our team has expertise in processing autologous and allogeneic hematopoietic progenitor cells (HPCs) derived from peripheral blood and bone marrow, as well as preparing cord blood units (HPC-CB) provided by private or public cord blood banks for transplantation. In addition to these CT products, the laboratory handles mononuclear cell (MNC) products, as well as investigational study products. The staff is comprised of board-certified medical laboratory scientists (MLS) who have received specialized training in the handling of cellular therapy products to include processing, cryopreservation and preparation for infusion.
Apheresis and Marrow Processing
Each CT product is routinely evaluated for ABO/Rh, total nucleated cell concentration, CD34 content if HPC or CD3 if MNC(A) or allogeneic HPC products, cell viability and microbial contamination. In addition, red cell compatibility and CD3 enumeration are performed on allogeneic HPC products. Other evaluations are available upon request.
Depending on the type of graft, the following manipulations are available:
Plasma reduction
Manual and automated methods of buffy coat preparations
T-Cell Depletion
CD34 Selection
Donor Lymphocyte Infusion (DLI) cell dosing
Cryopreservation and Storage
All cells are cryopreserved using a controlled-rate freezing process which allows for long-term storage of cells. The temperature of the cells is continuously monitored throughout the freezing process. When the cells reach approximately -90°C, they are transferred into a liquid nitrogen storage freezer.
Liquid nitrogen storage freezers:
Stored onsite in secure areas with authorized-access only
Colder than -150°C
Continuous temperature monitoring
Transportation and Infusion Support:
Carter BloodCare CT staff have the ability to receive, cryogenically store, transport and thaw products for local customers and transplant facilities based on the product and/or study protocol:
Cryopreserved products are transported in a validated liquid nitrogen shipper.
Liquid products, such as fresh marrow and thawed cord blood, are transported in a validated transport cooler.
Once at the patient’s bedside, the CT product is properly verified with the physician’s order and patient identification.
If cryopreserved, CT products are thawed by the CT lab at the patient’s bedside prior to issue.
Bone Marrow Collections
The CT laboratory has been trained in sterile surgical techniques and can assist the transplant physician in the operating room during bone marrow harvest procedures. The laboratory prepares an appropriate amount of suitable media to be used during the harvest and provides a sterile container for collected marrow. During the procedure, the CT technologist will monitor the amount of the harvested bone marrow. At the completion of the harvest, a member of our team will filter the bone marrow product and label according to established regulatory requirements.
Autologous and allogeneic bone marrow harvest assistance
Staff trained in surgical aseptic and sterile field techniques
HPC-Cord Blood Storage, Thawing and Infusion
Once the transplant facility selects a cord blood unit as a match for a patient, the transplant facility coordinates shipment and delivery of the selected cord blood unit to the CT laboratory. Upon arrival, the identity and the integrity of the product are verified and placed into a liquid nitrogen storage freezer until the patient is ready for transplant.
On the day of transplant, the CT laboratory will thaw the component and prepare it for transplant per the physician’s instructions:
Reconstitute prior to infusion
Wash and reconstitute to remove cryoprotectant and cellular debris prior to infusion